Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-17T05:15:22.721Z Has data issue: false hasContentIssue false
  • English
  • Français

Influence of microbiological culture results on antibiotic choices for veterans with hospital-acquired pneumonia and ventilator-associated pneumonia

Published online by Cambridge University Press:  04 June 2021

Taissa A. Bej ,
Robbie L. Christian ,
Sharanie V. Sims ,
Brigid M. Wilson ,
Sunah Song ,
Ukwen C. Akpoji ,
Robert A. Bonomo ,
Federico Perez  and
Robin L. P. Jump Open the ORCID record for Robin L. P. Jump [Opens in a new window]
Taissa A. Bej
Affiliation:
Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, Ohio
Robbie L. Christian
Affiliation:
Pharmacy Services, VA Northeast Ohio Healthcare System, Cleveland, Ohio
Sharanie V. Sims
Affiliation:
Pharmacy Services, VA Northeast Ohio Healthcare System, Cleveland, Ohio
Brigid M. Wilson
Affiliation:
Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, Ohio Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio
Sunah Song
Affiliation:
Cleveland Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio
Ukwen C. Akpoji
Affiliation:
Pharmacy Services, VA Northeast Ohio Healthcare System, Cleveland, Ohio
Robert A. Bonomo
Affiliation:
Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, Ohio Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio Departments of Pathology, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio
Federico Perez*
Affiliation:
Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, Ohio Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio
Robin L. P. Jump*
Affiliation:
Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, Ohio Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio
*
Author for correspondence: Robin L. P. Jump, E-mail: [email protected]. Or Federico Perez, E-mail: [email protected]
Author for correspondence: Robin L. P. Jump, E-mail: [email protected]. Or Federico Perez, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We examined the impact of microbiological results from respiratory samples on choice of antibiotic therapy in patients treated for hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP).

Design:

Four-year retrospective study.

Setting:

Veterans’ Health Administration (VHA).

Patients:

VHA patients hospitalized with HAP or VAP and with respiratory cultures between October 1, 2014, and September 30, 2018.

Interventions:

We compared patients with positive and negative respiratory culture results, assessing changes in antibiotic class and Antibiotic Spectrum Index (ASI) from the day of sample collection (day 0) through day 7.

Results:

Between October 1, 2014, and September 30, 2018, we identified 5,086 patients with HAP/VAP: 2,952 with positive culture results and 2,134 with negative culture results. All-cause 30-day mortality was 21% for both groups. The mean time from respiratory sample receipt in the laboratory to final respiratory culture result was longer for those with positive (2.9 ± 1.3 days) compared to negative results (2.5 ± 1.3 days; P < .001). The most common pathogens were Staphylococcus aureus and Pseudomonas aeruginosa. Vancomycin and β-lactam/β-lactamase inhibitors were the most commonly prescribed agents. The decrease in the median ASI from 13 to 8 between days 0 and 6 was similar among patients with positive and negative respiratory cultures. Patients with negative cultures were more likely to be off antibiotics from day 3 onward.

Conclusions:

The results of respiratory cultures had only a small influence on antibiotics used during the treatment of HAP/VAP. The decrease in ASI for both groups suggests the integration of antibiotic stewardship principles, including de-escalation, into the care of patients with HAP/VAP.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 5 , May 2022 , pp. 589 - 596
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

Present affiliation: Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana

References

Magill, SS, O’Leary, E, Janelle, SJ, et al. Changes in prevalence of health care-associated infections in US hospitals. N Engl J Med 2018;379:1732–1744.CrossRefGoogle Scholar
Muscedere, JG, Day, A, Heyland DK. Mortality, Attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis 2010;51 suppl 1:S120–S125.CrossRefGoogle Scholar
Melsen, WG, Rovers, MM, Groenwold, RHH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013;13:665–671.CrossRefGoogle ScholarPubMed
Kalil, AC, Metersky, ML, Klompas, M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61–e111.CrossRefGoogle Scholar
Zilberberg, MD, Nathanson, BH, Sulham, K, Fan, W, Shorr, AF. A novel algorithm to analyze epidemiology and outcomes of carbapenem resistance among patients with hospital-acquired and ventilator-associated pneumonia: a retrospective cohort study. Chest 2019;155:1119–1130.CrossRefGoogle ScholarPubMed
Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130–1139.CrossRefGoogle ScholarPubMed
Gerber, JS, Hersh, AL, Kronman, MP, Newland, JG, Ross, RK, Metjian, TA. Development and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals. Infect Control Hosp Epidemiol 2017;38:993–997.CrossRefGoogle ScholarPubMed
Development Core Team, R. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2017.Google Scholar
Grolemund, G, Wickham, H. Dates and times made easy with lubridate. J Statist Softw 2011;40(3):1–25.CrossRefGoogle Scholar
Wickham, H. The split-apply-combine strategy for data analysis. J Statist Softw 2011;40(1):1–29.CrossRefGoogle Scholar
Mahto, A. Splitstackshape: stack and reshape datasets after splitting concatenated values. CRAN website. https://cran.r-project.org/web/packages/splitstackshape/index.html. Published 2019. Accessed May 3, 2021.Google Scholar
Wickham, H, Averick, M, Bryan, J, et al. Welcome to the Tidyverse. J Open Source Softw 2019;4:1686.CrossRefGoogle Scholar
Therneau, T. A Package for Survival Analysis in R. R package version 3.2-11. 2021. https://CRAN.R-project.org/package=survival.Google Scholar
Kassambara, A, Kosinski, M, Biecek, P, Fabian, S. Survminer: drawing survival curves using “Ggplot2.” Survminer website. https://rpkgs.datanovia.com/survminer/2020. Accessed May 3, 2021.Google Scholar
Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
Dangerfield, B, Chung, A, Webb, B, Seville, MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 2014;58:859–864.CrossRefGoogle ScholarPubMed
Parente, DM, Cunha, CB, Mylonakis, E, Timbrook, TT. The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications. Clin Infect Dis 2018;67:1–7.CrossRefGoogle ScholarPubMed
Naidus, EL, LaSalvia, MT, Marcantonio, ER, Herzig, SJ. The diagnostic yield of noninvasive microbiologic sputum sampling in a cohort of patients with clinically diagnosed hospital-acquired pneumonia. J Hosp Med 2018;13:34–37.CrossRefGoogle Scholar
Ranzani, OT, Senussi, T, Idone, F, et al. Invasive and noninvasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia. Critical Care 2019;23:51.CrossRefGoogle Scholar
Weber, DJ, Rutala, WA, Sickbert-Bennett, EE, Samsa, GP, Brown, V, Niederman, MS. Microbiology of ventilator–associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007;28:825–831.CrossRefGoogle ScholarPubMed
Madaras-Kelly, K, Jones, M, Remington, R, et al. Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans’ Healthcare Administration. J Antimicrob Chemother 2016;71:539–546.CrossRefGoogle Scholar
Jones, BE, Jones, MM, Huttner, B, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006–2010. Clin Infect Dis 2015;61:1403–1410.CrossRefGoogle ScholarPubMed
O’Horo, JC, Thompson, D, Safdar, N. Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis 2012;55:551–561.CrossRefGoogle ScholarPubMed
Yoshimura, J, Yamakawa, K, Kinoshita, T, Ohta, Y, Morimoto, T. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial. Trials 2018;19:614.CrossRefGoogle ScholarPubMed
Enne, V, Baldan, R, Russell, C, et al. INHALE WP2: Appropriateness of antimicrobial prescribing for hospital-acquired and ventilator-associated pneumonia in UK ICUs assessed against PCR-based molecular diagnostic tests. Poster presented at: The 29th ECCMID, April 13th 2019; Amsterdam, Netherlands.Google Scholar
Ehren, K, Meißner, A, Jazmati, N, et al. Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections. Clin Infect Dis 2020;70:1285–1293.Google ScholarPubMed
Bohan, JG, Remington, R, Jones, M, Samore, M, Madaras-Kelly, K. Outcomes associated with antimicrobial de-escalation of treatment for pneumonia within the Veterans’ Healthcare Administration. Open Forum Infect Dis 2017;4(1):ofw244.CrossRefGoogle Scholar
Jones, BE, Brown, KA, Jones, MM, et al. Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US Veterans’ Affairs medical centers. Infect Control Hosp Epidemiol 2017;38:937–944.CrossRefGoogle Scholar
Bostwick, AD, Jones, BE, Paine, R, Goetz, MB, Samore, M, Jones, M. Potential impact of hospital-acquired pneumonia guidelines on empiric antibiotics. an evaluation of 113 Veterans’ Affairs medical centers. Ann Am Thorac Soc 2019;16:1392–1398.CrossRefGoogle Scholar
Tamma, PD, Aitken, SL, Bonomo, RA, Mathers, AJ, van Duin, D, Clancy, CJ. Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis 2021;72:e169–e183.CrossRefGoogle Scholar
Supplementary material: File

Bej et al. supplementary material

Tables S1-S2 and Figures S1-S3

Download Bej et al. supplementary material(File)
File 435.6 KB